New hope for rare Coin-Shaped eczema: drug trial shows promise
NCT ID NCT04600362
First seen Oct 31, 2025 · Last updated May 12, 2026 · Updated 20 times
Summary
This study tests if dupilumab, a drug already approved for eczema, can help people with nummular eczema (coin-shaped patches of itchy skin). About 70 adults with moderate-to-severe disease will receive either the drug or a placebo. The goal is to see if dupilumab reduces skin redness, scaling, and itching, improving quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NUMMULAR ECZEMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Klinikum re. Isar Dermatology
München, Bavaria, 81675, Germany
Conditions
Explore the condition pages connected to this study.